Dr. Fulmer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44106
Summary
- Dr. Clifton Fulmer is a pathologist in Cleveland, OH and is affiliated with multiple hospitals in the area, including the Cleveland Clinic. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 1 year. He specializes in gastrointestinal & hepatobiliary pathology, anatomic pathology, and surgical pathology.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2015 - 2019
- Rutgers Robert Wood Johnson Medical SchoolClass of 2015
- Graduate School of Biomedical Sciences, Rutgers UniversityPhD, Neuroscience and Cell Biology, 2007 - 2013
Certifications & Licensure
- OH State Medical License 2019 - 2027
- NY State Medical License 2017 - 2026
- American Board of Pathology Pathology - Anatomic
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational Profiles.Marco Matejcic, Jamie K Teer, Hannah J Hoehn, Diana B Diaz, Kritika Shankar
Cancer Research. 2025-03-24 - Building research infrastructure to advance precision medicine in colorectal cancer.Stephanie L Schmit, Nicole C Loroña, Daniel Sobieski, Marco Matejcic, Nathalie T Nguyen
JNCI Cancer Spectrum. 2025-03-20 - Definitions, Diagnosis and Management of Postoperative Recurrence in Crohn's Disease Patients with Permanent Ileostomy - A Systematic Review and Meta-Analysis.Suha Abushamma, Tesfaye Yadete, Neil Nero, Katherine Falloon, Claire E Parker
Journal of Crohn's & Colitis. 2025-03-10
Journal Articles
- CD30 + T Cell Enriched Primary Cutaneous CD4 + small/medium Sized Pleomorphic T Cell Lymphoma: A Distinct Variant of Indolent CD4 + T Cell Lymphoproliferative DiseaseClifton Fulmer, MD, ScienceDirect
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: